| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |